TECTONIC THERAPEUTIC INC (TECX) Stock News
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
TECX Latest News, Press Releases and Analysis
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved...
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
WATERTOWN, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”) a clinical stage biotechnology company focused...
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused...
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
Phase 1a results support further development of TX000045 (“TX45”) for Group 2 Pulmonary Hypertension in HFpEF (“PH-HFpEF”), based on favorable...
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
Patient enrollment in the Phase 1b hemodynamic trial remains ahead of expectation, with topline results now expected in late Q1’2025 or early Q2’2025First...
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
American Heart Association (AHA) poster to be presented on November 16, 2024
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
American Heart Association (AHA) poster to be presented on November 16, 2024...
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2...
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024
TECX stock results show that Tectonic Therapeutic missed analyst estimates for earnings per share the second quarter of 2024.
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tectonic Therapeutic (NASDAQ:TECX) just reported results for the second quarter...
Tectonic Therapeutic to Participate in September Investor Conferences
Tectonic Therapeutic to Participate in September Investor Conferences
Tectonic Therapeutic to Participate in September Investor Conferences...
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights ...
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45...
